Gene: DSTYK
Official Full Name: dual serine/threonine and tyrosine protein kinaseprovided by HGNC
Gene Summary: This gene encodes a dual serine/threonine and tyrosine protein kinase which is expressed in multiple tissues. It is thought to function as a regulator of cell death. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28840 | DSTYK Knockout cell line (HeLa) | Human | DSTYK | 1:3~1:6 | Negative | Online Inquiry |
KO28841 | DSTYK Knockout cell line (HCT 116) | Human | DSTYK | 1:2~1:4 | Negative | Online Inquiry |
KO28842 | DSTYK Knockout cell line (HEK293) | Human | DSTYK | 1:3~1:6 | Negative | Online Inquiry |
KO28843 | DSTYK Knockout cell line (A549) | Human | DSTYK | 1:3~1:4 | Negative | Online Inquiry |
DSTYK Gene Knockout Cell Lines are genetically engineered cellular models that have undergone targeted gene disruption of the DSTYK gene, a critical component involved in various signaling pathways and cellular processes. These cell lines are invaluable tools for researchers investigating the biological roles of the DSTYK gene and its potential implications in disease mechanisms. By utilizing CRISPR/Cas9 technology, our DSTYK Gene Knockout Cell Lines showcase the precision and efficiency characteristic of modern genetic manipulation techniques.
The primary function of these cell lines lies in their ability to elucidate the biological functions associated with the DSTYK gene, thus providing insights into its roles in cellular signaling, metabolism, and differentiation. Researchers can utilize these knockout models to study how the absence of the DSTYK gene affects various cellular responses, which may contribute to understanding its involvement in health and disease, including cancer and metabolic disorders.
From a scientific standpoint, DSTYK Gene Knockout Cell Lines are essential in both research and clinical settings. They serve as robust platforms for drug testing, gene therapy studies, and the development of targeted therapies. Their applications range from basic research to translational studies, making them a versatile tool for advancing our knowledge of gene function and pathogenesis.
One of the key advantages of our DSTYK Gene Knockout Cell Lines is their specificity and reproducibility. Unlike traditional knockout methods, our cell lines are generated using rigorously validated techniques that ensure consistent results and minimize off-target effects. This unique selling point gives researchers confidence in the reliability of their experimental outcomes compared to alternatives, which may compromise data integrity.
The value of DSTYK Gene Knockout Cell Lines lies in their potential to empower researchers and clinicians with precise models that enable the exploration of novel therapeutic strategies and the development of innovative treatments. By providing an accessible platform for gene function interrogation, these cell lines play a pivotal role in driving forward the fields of molecular biology and clinical research.
At our company, we are committed to supporting biomedical advancements with top-quality biological products backed by a team of experts dedicated to innovation and scientific excellence. Our DSTYK Gene Knockout Cell Lines exemplify this dedication, offering cutting-edge tools that enhance research capabilities and pave the way for future discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.